Synopsis
Movement Disorders Journal Podcasts 2012-2015
Episodes
-
![Cognitive impairment in “Other” movement disorders: Hidden defects and valuable clues]()
Cognitive impairment in “Other” movement disorders: Hidden defects and valuable clues
23/05/2014 Duration: 01min -
![The cognitive burden in Huntingtons disease: Pathology, phenotype, and mechanisms of compensation]()
The cognitive burden in Huntington's disease: Pathology, phenotype, and mechanisms of compensation
23/05/2014 Duration: 01min -
![Psychiatric issues in cognitive impairment]()
-
![Cognitive deficits in Parkinsons disease: A cognitive neuroscience perspective]()
Cognitive deficits in Parkinson's disease: A cognitive neuroscience perspective
23/05/2014 Duration: 01min -
![The spectrum of cognitive impairment in Lewy body diseases]()
-
![What can biomarkers tell us about cognition in Parkinsons disease?]()
-
![Volume 29 Issue 4 (2014)]()
-
![A randomized controlled trial of patient-reported outcomes with tai chi exercise in Parkinsons disease]()
A randomized controlled trial of patient-reported outcomes with tai chi exercise in Parkinson's disease
16/05/2014 Duration: 02min -
![Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinsons disease]()
Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
16/05/2014 Duration: 02min -
![ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinsons disease]()
ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease
16/05/2014 Duration: 02min -
![Reduced cortical plasticity and GABAergic modulation in essential tremor]()
-
![Essential tremor is not associated with cerebellar Purkinje cell loss]()
-
![Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial]()
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
16/05/2014 Duration: 02min -
![Rate of decline in progressive supranuclear palsy]()
-
![A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy]()
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
16/05/2014 Duration: 02min -
![Volume 27 Issue 1 (2012)]()
